- Home
- QIPT vs KOD Comparison
QIPT vs KOD Comparison
Compare QIPT & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QIPT
- KOD
- Stock Information
- Founded
- QIPT 1993
- KOD 2009
- Country
- QIPT United States
- KOD United States
- Employees
- QIPT N/A
- KOD N/A
- Industry
- QIPT
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- QIPT
- KOD Health Care
- Exchange
- QIPT Nasdaq
- KOD Nasdaq
- Market Cap
- QIPT 118.5M
- KOD 121.5M
- IPO Year
- QIPT N/A
- KOD 2018
- Fundamental
- Price
- QIPT $2.77
- KOD $2.84
- Analyst Decision
- QIPT Strong Buy
- KOD Hold
- Analyst Count
- QIPT 3
- KOD 5
- Target Price
- QIPT $7.67
- KOD $3.25
- AVG Volume (30 Days)
- QIPT 157.9K
- KOD 164.1K
- Earning Date
- QIPT 08-14-2024
- KOD 11-12-2024
- Dividend Yield
- QIPT N/A
- KOD N/A
- EPS Growth
- QIPT N/A
- KOD N/A
- EPS
- QIPT N/A
- KOD N/A
- Revenue
- QIPT $244,231,000.00
- KOD N/A
- Revenue This Year
- QIPT $24.82
- KOD N/A
- Revenue Next Year
- QIPT $4.54
- KOD N/A
- P/E Ratio
- QIPT N/A
- KOD N/A
- Revenue Growth
- QIPT 29.31
- KOD N/A
- 52 Week Low
- QIPT $2.60
- KOD $1.37
- 52 Week High
- QIPT $5.29
- KOD $7.77
- Technical
- Relative Strength Index (RSI)
- QIPT 45.51
- KOD 62.04
- Support Level
- QIPT $2.62
- KOD $2.54
- Resistance Level
- QIPT $2.82
- KOD $2.75
- Average True Range (ATR)
- QIPT 0.11
- KOD 0.15
- MACD
- QIPT 0.00
- KOD 0.02
- Stochastic Oscillator
- QIPT 35.94
- KOD 100.00
About QIPT Quipt Home Medical Corp.
Quipt Home Medical Corp provides in-home monitoring equipment, supplies, and services to patients. The company's services consist of Daily and Ambulatory Aides, Power Mobility, INR Self-Testing, Respiratory Equipment Rental, Home ventilation, Oxygen Therapy, and Sleep Apnea and PAP Treatment.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.